Study to Assess Pharmacodynamics, Clinical Effects, Safety and Pharmacokinetics of TAB08 in Patients With Psoriasis Vulgaris, Not Adequately Controlled With Current Concomitant Therapy
Phase of Trial: Phase I/II
Latest Information Update: 17 Feb 2017
At a glance
- Drugs Theralizumab (Primary)
- Indications Plaque psoriasis
- Focus Pharmacodynamics
- Sponsors TheraMAB
- 14 Feb 2017 Status changed from active, no longer recruiting to completed.
- 05 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 25 Jun 2016 New trial record